KRAS and malignant colon neoplasm: Our results contradict recent reports showing that KD did not prevent cachexia in a KRAS‐driven murine lung cancer model, a heterotopic C26 colon cancer model or the autochthonous genetically engineered KPC PDAC model.16, 34, 35